Cor Vasa 2019, 61(6):611-616 | DOI: 10.33678/cor.2019.078

(Atrial fibrallation in a cardiological practice - focused on amiodarone)

Jana Petrová, Karel Dvořák, Radim Kryza
Kardioplus s.r.o., Ostrava
Interní oddělení, Městská nemocnice Ostrava, Ostrava

Authors submit their own experiences with peroral using of amiodarone by patients who are suffering from an atrial fibrillation. They present a brief overview of metabolism of amiodarone, its registered dosage and side effects. By using very low doses and careful monitoring amiodarone is considered as a safe and effective antiarrhythmic.

Keywords: Amiodarone, Atrial fibrillation, Side effects

Received: November 11, 2019; Accepted: November 12, 2019; Published: December 15, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petrová J, Dvořák K, Kryza R. (Atrial fibrallation in a cardiological practice - focused on amiodarone). Cor Vasa. 2019;61(6):611-616. doi: 10.33678/cor.2019.078.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;38:2893-2962. Go to original source... Go to PubMed...
    2. Fiala M. Katétrová ablace fibrilace síní v prevenci mozkové cévní příhody. Interv akut Kardiol 2017;2:71-74. Go to original source...
    3. Shi LZ, Heng R, Liu SM, Leng FY. Effect of catheter ablation versus antiarrhythmic drug on atrial fibrillation: A meta- -analysis of randomized controlled trials. Exp Ther Med 2015;10:816-822. Go to original source... Go to PubMed...
    4. Echt D, Liebson P, Mitchell L, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhytmias Suppresion Trial. New Engl J Med 1991;12:781-788. Go to original source... Go to PubMed...
    5. Siddoway L. Amiodarone: Guidelines for use and monitoring. Am Fam Physician 2003;10:2189-2196.
    6. Connolly S. Evidence-Based analysis of Amiodarone efficacy and safety. Circulation 1999;100:2025-2034. Go to original source... Go to PubMed...
    7. Latini R, Tognoni G, Kates R. Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet 1984;2:136-156. Go to original source... Go to PubMed...
    8. Pollak P, Sharma A, Carruthers S. Creatinine elevation in patients receiving amiodarone correlates with serum concentration. Br J Clin Pharmacol 1993;2:125-127. Go to original source... Go to PubMed...
    9. Singh BN, Singh SN, Reda DJ, et al. Sotalol, Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005;18: 1861-1872. Go to original source... Go to PubMed...
    10. Rosenbaum M, Chiale P, Halpren M. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 1976;7:934-938. Go to original source... Go to PubMed...
    11. Dvořák K. Practical expiriences with administration of Cordarone in prevention, treatment and therapy of refractory supraventricular and ventricular arrhythmias in ambulatory practice. Symposium by Krka Pharmaceutical n.sol.o, Prague, 1981.
    12. Lukl J, Řezáčová M, Černošek B, et al. Užití amiodaronu v léčbě míhání síní odolného proti digoxinu. Vnitř Lék 1985;31:177-181. Go to PubMed...
    13. Roy D, Tlaic M, Dorian P, et al., Amiodaron to prevention recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;13:913-920. Go to original source... Go to PubMed...
    14. Zehender M, Hohnloser S, Muller B, et al. Effect of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results a comparative study and 2-year follow up. J Am Coll Cardiol 1992;19:1054-1059. Go to original source... Go to PubMed...
    15. Kochiadakis C, Ikoumenidis N, Marketou M, et al. Low dose amiodarone and sotalol in the treatment of the recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart 2000;3:151-154. Go to original source... Go to PubMed...
    16. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1427.
    17. Toulboul P, Brugada J, Cappucci A, et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 2003;24:1481-1487. Go to original source... Go to PubMed...
    18. Kober L, Torb-Pedersen C, McMurray J, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008;25:2678-2687. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes